RE:clinical trialsGreat details on the in place studies.
All with the same goal. To get Pelareorep to market , to improve people's lives.
Absolutely there are more.
My point was from an outcome point of view, the are millions of people/ year that will benifit.
Each trial for example involves the patients directly, their families. Also involved hoping for success the hundreds of health care workers & scientists involved.
Only a very few of shorters & bashers would be happy to see Onc fail.
With the recent FDA meeting request for phase 3 discussions, & the focus on increasing production, clearly the end goal is much closer.
The most clinical significant results lately , the pancreatic cancer trail with a Roche lead cancer drug tecentriq.
agreed 100%, the others that we know of.
pfizer, Incyte, Bms, and a very important biomarker lab company , name I forget. They were brought in to help with the bio- details in the Aware-1, study.
They are using technology not avaible 5 years ago.
it is that very technology & markers they are discussing with FDA.
If accepted, they will be able to tune the trial , very early.
AkA after only 2 weeks a simple blood draw will indicate if Pela will work for the individual or not.
For those with the desire. Take a deeper dive into Pelareorep as a cancer treatment.
No deal yet?
Mangement is saying multi billions, larger pharm saying let's see the data first.
The FDA meeting request & potential outcomes, could set up a wonderful opportunity.
Safe weekend all.
regards